Aemcolo for Noninvasive Escheria coli Infection

News
Article

Aemcolo Logo

Aemcolo (rifamycin, Cosmo Pharmaceuticals)

Indications: treatment of travelers’ diarrhea caused by noninvasive strains of Escherichia coli in adults.

Dosage: Two 388mg tablets taken orally, twice daily for three days.

Contraindications: known hypersensitivity to rifamycin, any of the other rifamycin class antimicrobial agents (e.g. rifaximin), or any of the components in AEMCOLO

Click here for more prescribing information

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Recent Videos
© 2025 MJH Life Sciences

All rights reserved.